+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases

The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases

Nihon Rinsho. Japanese Journal of Clinical Medicine 70(9): 1487-1491

The renin-angiotensin-aldosterone system(RAAS) plays a crucial role in the regulation of physiological homeostasis and diseases such as hypertension, coronary artery disease and chronic renal failure. In this cascade, the ACE/Ang II/AT1 receptor axis induces pathological effects, such as vasoconstriction, cell proliferation and fibrosis. Recently the ACE2/Ang(1-7)/Mas receptor axis has been recognized as a negative regulator of the RAAS. ACE2 metabolizes Ang II into Ang(1-7), which has opposite properties of Ang II through Mas receptor activation. Both animal and human studies provide strong evidence that the ACE2/Ang(1-7)/Mas receptor axis is protective for end-organ damage. Therefore, the ACE2/Ang(1-7)/Mas receptor axis could be a therapeutic target for coronary artery disease and chronic renal failure.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 056161682

Download citation: RISBibTeXText

PMID: 23012792

Related references

Ace2/Angiotensin-(1-7)/Mas Axis and Cardiovascular Regeneration. Current Hypertension Reviews 8(1): 35-46, 2012

Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling. International Journal of Hypertension 2012: 594361, 2012

Association between circulating levels of ACE2-Ang-(1-7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients. Medicine 95(24): E3876, 2017

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. British Journal of Pharmacology 169(3): 477-492, 2014

ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clinical Science 119(9): 385-394, 2010

The ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer. Frontiers in Physiology 8: 276, 2017

Circulating ACE2 in Cardiovascular and Kidney Diseases. Current Medicinal Chemistry 24(30): 3231-3241, 2017

ACE2: A novel therapeutic target for cardiovascular diseases. Progress in Biophysics and Molecular Biology 91(1-2): 163-198, 2005

Embarking Effect of ACE2-Angiotensin 1-7/Mas Receptor Axis in Benign Prostate Hyperplasia. Critical Reviews in Eukaryotic Gene Expression 28(2): 115-124, 2018

Targeting the Autotaxin - Lysophosphatidic Acid Receptor Axis in Cardiovascular Diseases. Biochemical Pharmacology 2019, 2019

Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 43(7): 738-746, 2018

The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction. Molecular Medicine Reports 16(2): 1973-1981, 2017

The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research. Current Drug Targets 18(11): 1301-1313, 2016

The role of ACE2, angiotensin-(1-7) and Mas1 receptor axis in glucocorticoid-induced intrauterine growth restriction. Reproductive Biology and Endocrinology 15(1): 97, 2018

Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors. Diabetes 62(4): 1258-1269, 2013